PMCTPharmaCountry
    Accueil

Actualités réglementaires

Évolutions réglementaires FDA, EMA, TGA et mondiales

#patient-reported outcomes ×

UPDATED
Actualités réglementaires
9 sept. 2026•1 min de lecture
Korea MFDS Expands GIFT Review to Include Patient Experience Data
The Korean MFDS revised its GIFT fast‑track guidelines, permitting patient‑reported symptoms, quality‑of‑life data, preferences, interviews, videos and written opinions as reference material for priority review of rare disease drugs.